208 related articles for article (PubMed ID: 16310587)
21. Abnormal neural activity in children with attention deficit hyperactivity disorder: a resting-state functional magnetic resonance imaging study.
Cao Q; Zang Y; Sun L; Sui M; Long X; Zou Q; Wang Y
Neuroreport; 2006 Jul; 17(10):1033-6. PubMed ID: 16791098
[TBL] [Abstract][Full Text] [Related]
22. Attention deficit/hyperactivity disorder in adults.
Moss SB; Nair R; Vallarino A; Wang S
Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
[TBL] [Abstract][Full Text] [Related]
23. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Fowler JS; Ding YS
Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
[TBL] [Abstract][Full Text] [Related]
24. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
Airaksinen E; Airaksinen MM
Duodecim; 2003; 119(16):1553-62. PubMed ID: 14535028
[No Abstract] [Full Text] [Related]
25. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
26. ADHD drugs and cardiovascular risk.
Wojnowski L
N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729376
[No Abstract] [Full Text] [Related]
27. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
Knight M
Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
[No Abstract] [Full Text] [Related]
28. Attention-deficit/hyperactivity disorder: a personal perspective.
Ginsberg ML
Adolesc Med State Art Rev; 2008 Aug; 19(2):339-51, xi-xii. PubMed ID: 18822837
[TBL] [Abstract][Full Text] [Related]
29. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
Bental B; Tirosh E
J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
[TBL] [Abstract][Full Text] [Related]
30. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
[TBL] [Abstract][Full Text] [Related]
31. Cerebral vasculitis following oral methylphenidate intake in an adult: a case report.
Thomalla G; Kucinski T; Weiller C; Röther J
World J Biol Psychiatry; 2006; 7(1):56-8. PubMed ID: 16428221
[TBL] [Abstract][Full Text] [Related]
32. [Emotional regulation and motivation in children with ADHD].
Høvik MF; Plessen KJ
Tidsskr Nor Laegeforen; 2010 Dec; 130(23):2349-52. PubMed ID: 21139659
[TBL] [Abstract][Full Text] [Related]
33. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
Taéron C
Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
[No Abstract] [Full Text] [Related]
34. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
35. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
36. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
[TBL] [Abstract][Full Text] [Related]
37. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
[No Abstract] [Full Text] [Related]
38. [After the researchers have left the field].
Boer F
Tijdschr Psychiatr; 2007; 49(8):525-7. PubMed ID: 17824135
[No Abstract] [Full Text] [Related]
39. Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD.
Semrud-Clikeman M; Pliśzka SR; Lancaster J; Liotti M
Neurology; 2006 Sep; 67(6):1023-7. PubMed ID: 17000972
[TBL] [Abstract][Full Text] [Related]
40. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
